Clinique des maladies lipidiques de Quebec

Québec, Quebec G1V 4W2

0 studies enrolling now · 7 studies all time

What they study most

Cardiovascular Disease, Familial Hypercholesterolemia, Hypercholesterolemia, Hyperlipidemia, Smoking Cessation

Studies at this site

• Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia — Completed
• Atorvastatin Three Year Pediatric Study — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins — Completed
• A Multi-National Study To Assess How Effective And Safe The Smoking Cessation Medicine Varenicline Is In Smokers Who Have Already Tried Varenicline In The Past As A Prescription Medicine From Their Usual Healthcare Provider — Completed